Morgan Stanley Analysts Give Commerzbank (CBK) a €9.50 Price Target

Share on StockTwits

Morgan Stanley set a €9.50 ($11.05) target price on Commerzbank (ETR:CBK) in a report published on Wednesday. The firm currently has a neutral rating on the financial services provider’s stock.

Several other research analysts also recently issued reports on CBK. Independent Research set a €7.00 ($8.14) price objective on shares of Commerzbank and gave the stock a neutral rating in a research report on Tuesday. JPMorgan Chase & Co. set a €11.00 ($12.79) price objective on shares of Commerzbank and gave the stock a buy rating in a research report on Monday, January 7th. Credit Suisse Group set a €9.00 ($10.47) price objective on shares of Commerzbank and gave the stock a neutral rating in a research report on Wednesday, October 3rd. HSBC set a €13.00 ($15.12) price objective on shares of Commerzbank and gave the stock a buy rating in a research report on Wednesday, October 24th. Finally, equinet set a €9.20 ($10.70) price objective on shares of Commerzbank and gave the stock a neutral rating in a research report on Thursday, November 8th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and seven have given a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of €9.79 ($11.38).

Shares of Commerzbank stock opened at €6.35 ($7.38) on Wednesday. Commerzbank has a 1 year low of €7.82 ($9.09) and a 1 year high of €13.82 ($16.07).

About Commerzbank

Commerzbank Aktiengesellschaft provides banking and capital market services to private and small business customers, corporate clients, multinationals, financial service providers, and institutional clients worldwide. It operates through Private and Small-Business Customers; Corporate Clients; and Asset & Capital Recovery segments.

Featured Story: How are institutional investors different from individual investors?

Analyst Recommendations for Commerzbank (ETR:CBK)

Receive News & Ratings for Commerzbank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Commerzbank and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Mercury Protocol 24-Hour Trading Volume Reaches $0.00
Mercury Protocol 24-Hour Trading Volume Reaches $0.00
Solarwindow Technologies  vs. Aemetis  Financial Survey
Solarwindow Technologies vs. Aemetis Financial Survey
Analyzing BIOQUAL  & Medpace
Analyzing BIOQUAL & Medpace
-$0.55 EPS Expected for ACADIA Pharmaceuticals Inc.  This Quarter
-$0.55 EPS Expected for ACADIA Pharmaceuticals Inc. This Quarter
Zacks: Analysts Expect Scotts Miracle-Gro Co  to Announce -$1.24 EPS
Zacks: Analysts Expect Scotts Miracle-Gro Co to Announce -$1.24 EPS
Cloud  Price Down 11.5% Over Last Week
Cloud Price Down 11.5% Over Last Week


Leave a Reply

 
© 2006-2019 Zolmax.